MedPath

Nitrofurantoin

Generic Name
Nitrofurantoin
Brand Names
Furadantin, Macrobid, Macrodantin
Drug Type
Small Molecule
Chemical Formula
C8H6N4O5
CAS Number
67-20-9
Unique Ingredient Identifier
927AH8112L
Background

Nitrofurantoin is a nitrofuran antibiotic used to treat uncomplicated urinary tract infections. Nitrofurantoin is converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein. This drug is more resistant to the development of bacterial resistance because it acts on many targets at once. Nitrofurantoin is a second line treatment to trimethoprim/sulfamethoxazole.

Nitrofurantoin was granted FDA approval on 6 February 1953.

Indication

Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.

Associated Conditions
Acute Cystitis, Urinary Tract Infection

Nitrofurantoin and Urinary Tract Infections (UTIs)

Not Applicable
Terminated
Conditions
Urinary Tract Infections
Interventions
First Posted Date
2008-05-15
Last Posted Date
2016-09-27
Lead Sponsor
University of Pittsburgh
Target Recruit Count
10
Registration Number
NCT00678041
Locations
🇺🇸

Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
71
Registration Number
NCT00649285
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
28
Registration Number
NCT00649506
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Short Course Nitrofurantoin for Acute Cystitis

Phase 2
Completed
Conditions
Urinary Tract Infection
Interventions
Drug: TMP/SMX DS twice daily x 3 days
First Posted Date
2006-10-24
Last Posted Date
2014-06-05
Lead Sponsor
University of Washington
Target Recruit Count
338
Registration Number
NCT00391651
Locations
🇺🇸

University of WA, Seattle, Washington, United States

Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis

Phase 4
Withdrawn
Conditions
Cystitis
First Posted Date
2006-08-09
Last Posted Date
2007-03-02
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
400
Registration Number
NCT00361998
Locations
🇮🇱

Research Unit, Clalit Health Services, Haifa and Western Galillee District, Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath